Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0F5MZ
|
||||
| Former ID |
DNC011152
|
||||
| Drug Name |
4-(2'-(trifluoromethyl)biphenyl-3-yl)oxazole
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [531103] | ||
| Formula |
C16H10F3NO
|
||||
| Canonical SMILES |
C1=CC=C(C(=C1)C2=CC(=CC=C2)C3=COC=N3)C(F)(F)F
|
||||
| InChI |
1S/C16H10F3NO/c17-16(18,19)14-7-2-1-6-13(14)11-4-3-5-12(8-11)15-9-21-10-20-15/h1-10H
|
||||
| InChIKey |
SRZDIBWHWBVAAW-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Voltage-gated sodium channel subunit alpha Nav1.7 | Target Info | Inhibitor | [531103] | |
| Reactome | Interaction between L1 and Ankyrins | ||||
| References | |||||